Finding Success with Moderate to Severe Atopic Dermatitis

Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

New Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation

Mount Sinai Dermatology Experts Present Three Late-Breaking Research Papers at European Academy of Dermatology and Venereology Congress 2023

Learning the Language of Cells to Beat Cancer

New RNA-based Therapy Combats Melanoma in Mouse Models

New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition

As acquisitions dip and layoffs abound, New York's tech firms focus on pharma

Mount Sinai Researchers Awarded $12 Million NIH Grant to Create a Center to Unravel Novel Causes of Food Allergy and Atopic Dermatitis

Mount Sinai Physician Pays It Forward: $5 Million Bequest Promised to Support the Kimberly and Eric J. Waldman Department of Dermatology

Eczema: Experimental drug shows promise in treating atopic dermatitis

New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results